SubjectWell
BRANY
BRANY was founded by the country’s leading academic medical centers in 1998, and has a stellar track record of working with community and academic hospitals and established investigators. BRANY understands the importance of high quality human subject research. In today’s increasingly complex study environment, we excel in helping IRB’s and hospitals continue to provide their patients with high quality clinical research. BRANY offers personalized customer service and project management, as well as ongoing communication through our quarterly newsletter and regular email updates
Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Advarra
Schulman IRB and Chesapeake IRB have merged to create Advarra, the premier provider of IRB, IBC and global research compliance services. By integrating our innovative technology and proven regulatory expertise, Advarra helps ensure the highest standards of human research protections. Advarra supports all research phases across all major therapeutic areas.
PRA Health Sciences
We are dedicated to the future of clinical development and to every life it saves.